Home›Lactulose Solution Usp, 10 G/15 Ml

Lactulose Solution Usp, 10 G/15 Ml

Also known as: Lactulose Solution

Osmotic LaxativeOsmotic ActivityAcidifying Activity

Route: Oral, Rectal

Check Lactulose Solution Usp, 10 G/15 Ml Interactions →

4 interactions on record

Lactulose Solution Usp, 10 G/15 Ml has 4 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Antacids Containing Calcium, Anti-Infective Agents, Laxatives. Patients taking Lactulose Solution Usp, 10 G/15 Ml should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 4
Moderate: 4

Moderate (4)

Lactulose Solution Usp, 10 G/15 Ml + Antacids Containing Calcium— Nonabsorbable antacids given concurrently may inhibit the desired lactulose-induced drop in colonic pH, potentially redu…
Lactulose Solution Usp, 10 G/15 Ml + Anti-Infective Agents— Anti-infective agents may eliminate colonic bacteria and interfere with desired degradation of lactulose and acidificati…
Lactulose Solution Usp, 10 G/15 Ml + Laxatives— Other laxatives should not be used concurrently, especially during initial phase of portal-systemic encephalopathy thera…
Lactulose Solution Usp, 10 G/15 Ml + Neomycin— Elimination of colonic bacteria by neomycin may interfere with lactulose degradation and prevent acidification of coloni…

Lactulose Solution Usp, 10 G/15 Ml + Antacids Containing Calcium🟡Moderate

Nonabsorbable antacids given concurrently may inhibit the desired lactulose-induced drop in colonic pH, potentially reducing treatment efficacy.

Lactulose Solution Usp, 10 G/15 Ml + Anti-Infective Agents🟡Moderate

Anti-infective agents may eliminate colonic bacteria and interfere with desired degradation of lactulose and acidification of colonic contents.

Lactulose Solution Usp, 10 G/15 Ml + Laxatives🟡Moderate

Other laxatives should not be used concurrently, especially during initial phase of portal-systemic encephalopathy therapy, as loose stools may falsely suggest adequate lactulose dosage.

Lactulose Solution Usp, 10 G/15 Ml + Neomycin🟡Moderate

Elimination of colonic bacteria by neomycin may interfere with lactulose degradation and prevent acidification of colonic contents. Patient status should be closely monitored.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.